Ellen Bolotin

Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7

Ellen Bolotin, Monika Smogorzewska, Susan M. Smith et al. · Blood · 1996 · 220 citations · Full text

Life Sciences, Hematology, Immunology +12

Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count

Ellen Bolotin, Geralyn Annett, Robertson Parkman et al. · Bone Marrow Transplantation · 1999 · 216 citations

Life Sciences, Hematology, Immunology +8

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

D. Ross Camidge, Jair Bar, Hidehito Horinouchi et al. · Journal of Clinical Oncology · 2024 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17

Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive Therapy

Carolyn E. Behrendt, Joseph Rosenthal, Ellen Bolotin et al. · Biology of Blood and Marrow Transplantation · 2009 · 73 citations · Full text

Medicine, Hematology, Pediatrics +17

Telisotuzumab vedotin (Teliso-V) monotherapy in patients (pts) with previously treated c-Met–overexpressing (OE) advanced non-small cell lung cancer (NSCLC).

D. Ross Camidge, Jair Bar, Hidehito Horinouchi et al. · Journal of Clinical Oncology · 2022 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +17